One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates (Q35140303)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates |
scientific article |
Statements
1 reference
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates (English)
1 reference
Jacob D Estes
1 reference
Florence Othieno
1 reference
Deborah A Payne
1 reference
John F Krisko
1 reference
Youn Tae Kwak
1 reference
Francisco Martinez-Torres
1 reference
Wei Zou
1 reference
Elisa Fleming
1 reference
Sima Zein
1 reference
Angela Wahl
1 reference
Brett D Welch
1 reference
Michael S Kay
1 reference
Philippe Gallay
1 reference
Ettore Appella
1 reference
Min Lu
1 reference
J Victor Garcia
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference